-terone
Drugs that block androgens, like abiraterone.
- Drugs ending in -terone: 26
- Approved somewhere: 13
- With a US drug page: 16
- Stem
- -terone
- Class
- Drugs that block androgens, like abiraterone
Approved and clinical-stage drugs in ChEMBL whose names ending in -terone, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Abiraterone | Approved | CYP17A1, AR, Steroid 5-alpha-reductase | Cytochrome P450 17A1 inhibitor |
| Abiraterone acetate | Approved | CYP17A1 | Cytochrome P450 17A1 inhibitor |
| Clascoterone | Approved | AR | Androgen Receptor antagonist |
| Fluoxymesterone | Approved | AR | Androgen Receptor agonist |
| Hydroxyprogesterone caproate | Approved | PGR | Progesterone receptor agonist |
| Medroxyprogesterone acetate | Approved | PGR | Progesterone receptor agonist |
| Methyltestosterone | Approved | AR | Androgen Receptor agonist |
| Prasterone | Approved | — | Unknown |
| Progesterone | Approved | PGR | Progesterone receptor agonist |
| Testosterone | Approved | AR | Androgen Receptor agonist |
| Testosterone cypionate | Approved | AR | Androgen Receptor agonist |
| Testosterone enanthate | Approved | AR | Androgen Receptor agonist |
| Testosterone undecanoate | Approved | AR | Androgen Receptor agonist |
| Dydrogesterone | Phase 3 | PGR | Progesterone receptor agonist |
| Desoxycorticosterone acetate | — | NR3C2 | Mineralocorticoid receptor agonist |
| Desoxycorticosterone pivalate | — | NR3C2 | Mineralocorticoid receptor agonist |
| Corticosterone | Phase 3 | — | — |
| Cyproterone acetate | Phase 3 | AR, NR3C1, PGR | Androgen Receptor antagonist |
| Ethisterone | Phase 3 | — | — |
| Galeterone | Phase 3 | AR, CYP17A1 | Androgen Receptor antagonist |
| Fluorofuranylnorprogesterone | Phase 2 | — | — |
| Abiraterone decanoate | Phase 1 | — | — |
| Testosterone propionate | Phase 1 | AR | Androgen Receptor agonist |
| Cyproterone | Early phase 1 | — | — |
| Osaterone acetate | — | AR | Androgen receptor antagonist |
| Segesterone acetate | — | PGR | Progesterone receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO